Stock HSIC HENRY SCHEIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
73.13 USD +0.43% Intraday chart for Henry Schein, Inc. +3.20% -3.41%
Apr. 12 Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating MT
Apr. 12 Constellation Brands, Inc: Cash machine Our Logo

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,749 9,400 10,810 10,826 9,838 9,398 - -
Enterprise Value (EV) 1 10,400 9,678 11,564 11,858 12,018 11,230 10,954 10,918
P/E ratio 14.3 x 23.3 x 17.5 x 20.4 x 24 x 16.4 x 14.5 x 13.1 x
Yield - - - - - - - -
Capitalization / Revenue 0.98 x 0.93 x 0.87 x 0.86 x 0.8 x 0.7 x 0.67 x 0.63 x
EV / Revenue 1.04 x 0.96 x 0.93 x 0.94 x 0.97 x 0.84 x 0.78 x 0.74 x
EV / EBITDA 11.3 x 12.9 x 10.8 x 12.4 x 12.2 x 9.66 x 8.76 x 8.01 x
EV / FCF 18 x 17.6 x 18.3 x 23.4 x 34 x 15.1 x 15.1 x 13.4 x
FCF Yield 5.56% 5.68% 5.45% 4.27% 2.94% 6.64% 6.62% 7.49%
Price to Book 3.18 x 2.8 x 3.12 x 3.05 x 2.68 x 2.05 x 1.8 x 1.59 x
Nbr of stocks (in thousands) 146,740 142,776 138,674 135,548 129,938 128,506 - -
Reference price 2 66.44 65.84 77.95 79.87 75.71 73.13 73.13 73.13
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,986 10,119 12,401 12,647 12,339 13,420 14,076 14,854
EBITDA 1 917.9 752.9 1,069 959 984 1,163 1,250 1,363
EBIT 1 733 567.4 859.6 747 615 895.6 964.2 1,022
Operating Margin 7.34% 5.61% 6.93% 5.91% 4.98% 6.67% 6.85% 6.88%
Earnings before Tax (EBT) 1 680.3 499.9 830.5 721 542 853.3 939.4 1,034
Net income 1 694.7 403.8 631.2 538 416 610.6 672.7 750.1
Net margin 6.96% 3.99% 5.09% 4.25% 3.37% 4.55% 4.78% 5.05%
EPS 2 4.650 2.820 4.450 3.910 3.160 4.464 5.060 5.583
Free Cash Flow 1 577.9 550.1 630.6 506 353 745.9 724.8 817.7
FCF margin 5.79% 5.44% 5.08% 4% 2.86% 5.56% 5.15% 5.5%
FCF Conversion (EBITDA) 62.95% 73.06% 58.98% 52.76% 35.87% 64.15% 57.98% 59.99%
FCF Conversion (Net income) 83.18% 136.23% 99.89% 94.05% 84.86% 122.15% 107.75% 109.01%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 3,178 3,331 3,179 3,030 3,067 3,371 3,060 3,100 3,162 3,017 3,206 3,301 3,390 3,527 3,397
EBITDA 1 262.2 263.8 299 273 263 124 257 250 259 172 238.3 287.1 306.5 314.9 288.4
EBIT 1 210.6 205.1 244 220 211 72 175 201 200 39 183.6 225.7 239 247 203.2
Operating Margin 6.63% 6.16% 7.68% 7.26% 6.88% 2.14% 5.72% 6.48% 6.33% 1.29% 5.73% 6.84% 7.05% 7% 5.98%
Earnings before Tax (EBT) 1 206.1 193 239 214 205 63 163 186 179 14 171.1 212.7 224.1 228.9 200.8
Net income 1 162.3 147.2 181 160 150 47 121 140 137 18 123.7 152.3 163 171.3 145.2
Net margin 5.11% 4.42% 5.69% 5.28% 4.89% 1.39% 3.95% 4.52% 4.33% 0.6% 3.86% 4.61% 4.81% 4.86% 4.27%
EPS 2 1.150 1.050 1.300 1.160 1.090 0.3400 0.9100 1.060 1.050 0.1300 0.8438 1.103 1.216 1.268 1.144
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/2/21 2/15/22 5/3/22 8/2/22 11/1/22 2/16/23 5/9/23 8/7/23 11/13/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 651 278 755 1,032 2,180 1,833 1,556 1,520
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.7088 x 0.3689 x 0.7058 x 1.076 x 2.215 x 1.576 x 1.245 x 1.115 x
Free Cash Flow 1 578 550 631 506 353 746 725 818
ROE (net income / shareholders' equity) 23.3% 12.7% 18.6% 18.2% 16.7% 14.7% 14.9% 14.1%
ROA (Net income/ Total Assets) 8.88% 5.41% 7.88% 8.67% 6.18% 6.12% 6.47% 6.43%
Assets 1 7,826 7,462 8,008 6,205 6,731 9,971 10,400 11,663
Book Value Per Share 2 20.90 23.50 25.00 26.10 28.30 35.60 40.60 45.90
Cash Flow per Share 2 4.380 4.180 5.010 4.370 3.800 7.520 6.200 -
Capex 1 76.2 48.8 79 96 147 110 117 107
Capex / Sales 0.76% 0.48% 0.64% 0.76% 1.19% 0.82% 0.83% 0.72%
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Henry Schein, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
73.13 USD
Average target price
80.63 USD
Spread / Average Target
+10.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

1st Jan change Capi.
HENRY SCHEIN, INC. Stock Henry Schein, Inc.
-3.41% 9.4B
OWENS & MINOR, INC. Stock Owens & Minor, Inc.
+30.20% 1.92B
SHIP HEALTHCARE HOLDINGS, INC. Stock Ship Healthcare Holdings, Inc.
-3.90% 1.39B
AS ONE CORPORATION Stock AS ONE Corporation
-7.38% 1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD. Stock GKHT Medical Technology Co., Ltd.
-18.42% 857M
TOKAI CORP. Stock TOKAI Corp.
+0.48% 470M
EXCELSIOR MEDICAL CO., LTD. Stock Excelsior Medical Co., Ltd.
+3.62% 437M
GAUSH MEDITECH LTD Stock Gaush Meditech Ltd
-49.68% 360M
COWEALTH MEDICAL CHINA CO.,LTD. Stock Cowealth Medical China Co.,Ltd.
-24.72% 333M
WIN-PARTNERS CO., LTD. Stock WIN-Partners Co., Ltd.
-2.42% 212M
Medical Equipment Wholesale
  1. Stock Market
  2. Equities
  3. HSIC Stock
  4. Financials Henry Schein, Inc.